Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Behavioural Brain Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 9062678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine

  2004cited by this paper
• Attenuation of scopolamine-induced impairment of spontaneous alternation behaviour by antagonist but not inverse agonist and agonist β-carbolines

  2004cited by this paper
• Unlike β-endorphin, dynorphin1–13 does not cause retrograde amnesia for shuttle avoidance or inhibitory avoidance learning in rats

  2004cited by this paper
• Dopaminergic involvement in the improving effects of dynorphin A-(1-13) on scopolamine-induced impairment of alternation performance.

  1993cited by this paper
• U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice.

  1993cited by this paper
• Dynorphin A-(1-13) attenuates basal forebrain-lesion-induced amnesia in rats.

  1993cited by this paper
• Lesioning of the nucleus basalis of Meynert has differential effects on mu, delta and kappa opioid receptor binding in rat brain: a quantitative autoradiographic study.

  1992cited by this paper
• Effect of centrally administered atropine and pirenzepine on radial arm maze performance in the rat.

  1991cited by this paper
• Production of antisera selective for m1 muscarinic receptors using fusion proteins: distribution of m1 receptors in rat brain.

  1991cited by this paper
• Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies

  1991cited by this paper
• Effect of selective muscarinic receptor agonists and antagonists on active-avoidance learning acquisition in rats.

  1991cited by this paper
• Dynorphin1-17 can enhance or impair retention of an inhibitory avoidance response in rats.

  1990cited by this paper
• Microinjection of dynorphin into the hippocampus impairs spatial learning in rats.

  1990cited by this paper
• Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea-pig and rat.

  1989cited by this paper
• The effect of pirenzepine on spatial learning in the Morris Water Maze.

  1988cited by this paper
• Cholinergic-dopaminergic interactions in radial-arm maze performance.

  1988cited by this paper
• Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.

  1988cited by this paper
• Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients.

  1987cited by this paper
• Central administration of the muscarinic receptor subtype ‐ selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse

  1983cited by this paper
• Cholinergic underactivity in human memory disorders.

  1978cited by this paper
• Neocortical cholinergic neurons in elderly people.

  1977cited by this paper
• Memory and cognitive function in man

  1977cited by this paper
• Necropsy evidence of central cholinergic deficits in senile dementia.

  1977cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

  1957cited by this paper

• The Cholinergic Receptor Nicotinic α3 Was Reduced in the Hippocampus of Early Cognitively Impaired Adult Male Mice and Upregulated by Nicotine and Cytisine in HT22 Cells

  2025cites this paper
• Dasatinib plus quercetin attenuates some frailty characteristics in SAMP10 mice

  2022cites this paper
• Short- and long-term administration of buprenorphine improved gene expression of P2X4 and GABAA receptors in the hippocampus of methamphetamine rats

  2022cites this paper
• Dichotomous regulation of striatal plasticity by dynorphin

  2022cites this paper
• Perinatal exposure to a glyphosate-based herbicide causes dysregulation of dynorphins and an increase of neural precursor cells in the brain of adult male rats.

  2021cites this paper
• Zebrafish models relevant to studying central opioid and endocannabinoid systems

  2018cites this paper
• Spontaneous alternation behavior in larval zebrafish

  2017cites this paper
• The major neurotransmitter systems in the basolateral amygdala and the ventral tegmental area mediate morphine-induced memory consolidation impairment.

  2017cites this paper
• Memory-enhancing effect of aspirin is mediated through opioid system modulation in an AlCl3-induced neurotoxicity mouse model.

  2016cites this paper
• La comorbidité entre dépendance aux opiacés et dépression : mécanismes sérotoninergiques dans un modèle murin

  2012cites this paper
• Protection of brain and pancreas from high-fat diet: effects of catechin and caffeine.

  2009cites this paper
• Sensorimotor gating and attentional set-shifting are improved by the mu-opioid receptor agonist morphine in healthy human volunteers.

  2008cites this paper
• Dysregulation of dynorphins in Alzheimer disease.

  2007cites this paper
• Hippocampal gene expression profiling reveals the possible involvement of Homer1 and GABAB receptors in scopolamine‐induced amnesia

  2007cites this paper
• Spectroscopic studies of dynorphin neuropeptides and the amyloid beta-peptide : The consequences of biomembrane interactions

  2007cites this paper
• Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice.

  2007cites this paper
• AGING AND THE DYNORPHINERGIC SYSTEM: EVALUATION OF MEMORY AND MOTOR SYSTEMS IN PRODYNORPHIN KNOCKOUT MICE

  2007cites this paper
• Neurotransmitters and cognition.

  2006cites this paper
• Big Dynorphin, a Prodynorphin-Derived Peptide Produces NMDA Receptor-Mediated Effects on Memory, Anxiolytic-Like and Locomotor Behavior in Mice

  2006cites this paper
• Searching for the Optimal Combinations of Regulatory Anxiolytic Peptides: A Theoretical Basis

  2004cites this paper
• Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice.

  2004cites this paper
• Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10).

  2004cites this paper
• The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory.

  2004cites this paper
• Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity.

  2003cites this paper
• Effects of histamine and opioid systems on memory retention of passive avoidance learning in rats.

  2002cites this paper
• The neurobiological basis of spontaneous alternation.

  2002cites this paper
• Peripheral electric stimulation attenuates the expression of cocaine-induced place preference in rats.

  2002cites this paper
• PII: S0006-8993(02)03614-4

  2002cites this paper
• Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against various Gi-protein alpha subunits.

  2001cites this paper
• U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice.

  2000cites this paper
• A way of functional classification of regulatory peptides. Parameters of divergent and convergent evolution of regulatory peptides

  2000cites this paper
• Roles of kappa-opioid receptor agonists in learning and memory impairment in animal models.

  1998cites this paper
• mu-Opposing actions of the kappa-opioid receptor.

  1998cites this paper
• The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part III: animal model.

  1998cites this paper
• Endogenous opiates: 1997.

  1998cites this paper